Clearside Biomedical
CLSD
CLSD
54 hedge funds and large institutions have $13.6M invested in Clearside Biomedical in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 20 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
2.18% less ownership
Funds ownership: 21.61% → 19.43% (-2.2%)
32% less capital invested
Capital invested by funds: $20.1M → $13.6M (-$6.52M)
60% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 20
Holders
54
Holding in Top 10
1
Calls
$221K
Puts
$218K
Top Buyers
| 1 | +$104K | |
| 2 | +$25K | |
| 3 | +$19.4K | |
| 4 |
CG
Carmignac Gestion
Paris,
France
|
+$11.3K |
| 5 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$6.83K |
Top Sellers
| 1 | -$547K | |
| 2 | -$390K | |
| 3 | -$169K | |
| 4 |
Millennium Management
New York
|
-$165K |
| 5 |
Two Sigma Advisers
New York
|
-$157K |